Arginine shows promise as low-cost weapon against Alzheimer’s in animal studies
Read with caution - this story is only being covered by one news source that has a ‘low factuality’ rating, which means the outlet has a history of poor reporting practices. Learn more about factuality ratings here.2 Articles
2 Articles
Arginine shows promise as low-cost weapon against Alzheimer’s in animal studies
Researchers at Kindai University in Japan found that oral arginine, a common amino acid, reduced toxic amyloid protein buildup in fruit flies and mice genetically modified to model Alzheimer’s disease. Laboratory tests showed arginine prevented the formation of amyloid beta aggregates, with stronger effects at higher concentrations. Treated mice showed fewer brain plaques, lower brain […]
Alzheimer's is the most common form of dementia. Around 50 million people worldwide are said to be affected by it. The increasing ageing of the population in industrial nations ensures significant growth rates in Alzheimer's. Alzheimer's is mainly characterized by extracellular deposition of amyloid-β (Aβ) plaques and intracellular neurofibrillary tangles, which consist of hyperphosphorylated tangles, whereby the agglomeration of amyloids is...
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
